Exhibit 10.27

SHADY GROVE INNOVATION CENTER

f/k/a

MARYLAND TECHNOLOGY DEVELOPMENT CENTER

LICENSE AGREEMENT

AMENDMENT 12

This addendum is made this 12 day of February, 2010, by and between MEDCO and Neogenix Oncology, Inc. (“Licensee”).

WHEREAS, MEDCO and Licensee have entered into a License Agreement dated April 28, 2004;

WHEREAS, Licensee currently occupies Labs #211, #222 and #226, and offices #260, #261, #262, #267, #317 and #318 in the Shady Grove Innovation Center f/k/a Maryland Technology Development Center in Montgomery County, Maryland (the “Original Premises”);

WHEREAS Licensee wishes to expand and renew its office space within the Shady Grove Innovation Center and MEDCO is willing to provide for such expansion and renewal based on the terms provided for below;

NOW, THEREFORE, in consideration of the mutual covenants and agreements stated herein, the parties agree as follows:

1. Effective March 1, 2010, Licensee shall occupy office #118 (the “Expansion Premises”).

2. The Monthly Payment, for the Expansion Premises, provided herein shall be as follows:

From March 1, 2010 to April 30, 2011 $ 125

3. The aggregate Monthly Payment, to include the Monthly Payment for the Original Premises and the Expansion Premises provided for herein shall be as follows:

From March 1, 2010 to April 30, 2011		15,174
Renewal Term:
From May 1, 2011 to April 30, 2012	$	16,691

4. All other provisions of the original License Agreement shall apply to this Amendment

This Amendment may be signed in counterparts.

FOR:	Maryland Economic Development Corporation	FOR:	Neogenix Oncology, Inc.
BY:		BY:
	Scheer Partners, Inc. SGIC Manager
Date:	2/12/2010	Date:	2.12.2010
BY:	/s/ Robert C. Brennan
	Robert C. Brennan
	Executive Director, MEDCO
Date:	2/22/10